Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Alton Shader sold 15,000 shares of the company’s stock in a transaction dated Thursday, March 16th. The stock was sold at an average price of $69.34, for a total transaction of $1,040,100.00. Following the completion of the sale, the senior vice president now directly owns 52,638 shares of the company’s stock, valued at $3,649,918.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) traded down 0.31% during trading on Monday, hitting $69.85. 544,601 shares of the company traded hands. Hill-Rom Holdings, Inc. has a 52-week low of $46.13 and a 52-week high of $70.30. The stock has a market capitalization of $4.56 billion, a PE ratio of 32.53 and a beta of 1.20. The company has a 50-day moving average of $64.16 and a 200-day moving average of $59.40.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, January 27th. The medical technology company reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The company earned $637.40 million during the quarter, compared to the consensus estimate of $654.12 million. Hill-Rom Holdings had a return on equity of 19.12% and a net margin of 5.44%. Hill-Rom Holdings’s revenue was down 3.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.68 EPS. Equities analysts expect that Hill-Rom Holdings, Inc. will post $3.81 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 31st. Shareholders of record on Friday, March 24th will be given a $0.18 dividend. This is an increase from Hill-Rom Holdings’s previous quarterly dividend of $0.17. This represents a $0.72 annualized dividend and a yield of 1.03%. The ex-dividend date is Wednesday, March 22nd. Hill-Rom Holdings’s payout ratio is currently 31.78%.

Your IP Address:

A number of analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, February 2nd. Barclays PLC started coverage on shares of Hill-Rom Holdings in a research note on Wednesday, February 8th. They issued an “overweight” rating and a $70.00 price objective for the company. Finally, Stifel Nicolaus started coverage on shares of Hill-Rom Holdings in a research report on Monday, January 23rd. They set a “buy” rating and a $70.00 price target for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $65.14.

A number of institutional investors have recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in Hill-Rom Holdings during the fourth quarter valued at $36,707,000. Victory Capital Management Inc. increased its position in Hill-Rom Holdings by 58.6% in the third quarter. Victory Capital Management Inc. now owns 634,549 shares of the medical technology company’s stock valued at $39,330,000 after buying an additional 234,415 shares in the last quarter. Cornerstone Capital Management Holdings LLC. increased its position in Hill-Rom Holdings by 257.3% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 319,507 shares of the medical technology company’s stock valued at $19,802,000 after buying an additional 230,076 shares in the last quarter. Bogle Investment Management L P DE purchased a new position in Hill-Rom Holdings during the fourth quarter valued at $12,698,000. Finally, Prudential PLC increased its position in Hill-Rom Holdings by 43.7% in the fourth quarter. Prudential PLC now owns 674,000 shares of the medical technology company’s stock valued at $37,838,000 after buying an additional 205,100 shares in the last quarter. 83.53% of the stock is owned by institutional investors.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

5 Day Chart for NYSE:HRC

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.